Tower Research Capital LLC (Trc) Blue Water Vaccines Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	4,417 Added 52.83%	12,777 $2,000
Q1 2024 May 15, 2024	BUY	$0.15 - $0.32 $7 - $16	53 Added 0.64%	8,360 $1,000
Q4 2023 Feb 13, 2024	BUY	$0.18 - $0.52 $47 - $136	262 Added 3.26%	8,307 $1,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.2 $525 - $1,237	1,031 Added 14.7%	8,045 $4,000
Q2 2023 Aug 14, 2023	BUY	$0.79 - $1.29 $3,130 - $5,112	3,963 Added 129.89%	7,014 $7,000
Q1 2023 May 09, 2023	SELL	$1.01 - $1.56 $7,115 - $10,990	-7,045 Reduced 69.78%	3,051 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.92 - $1.46 $8,994 - $14,274	9,777 Added 3064.89%	10,096 $11,000
Q3 2022 Nov 10, 2022	BUY	$1.78 - $6.66 $567 - $2,124	319 New	319 $1,000

53.6K

Ticker BWV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,744,900
Market Cap $2.34M
Description
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.